| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/24/2003 | WO2002094177A3 Novel nucleic acids and their therapeutic use in ophthalmology |
| 12/24/2003 | WO2002092764A3 Transgenic animal model of bone mass modulation |
| 12/24/2003 | WO2002090542A3 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 12/24/2003 | WO2002088375A3 Compositions and methods relating to breast specific genes and proteins |
| 12/24/2003 | WO2002087505A3 3-structure of a whole integrin $g(a)v$g(b)3 extracellular region and uses therefor |
| 12/24/2003 | WO2002083851A3 Vegf fusion proteins |
| 12/24/2003 | WO2002081498A9 Novel proteins and nucleic acids encoding same |
| 12/24/2003 | WO2002077186A3 Human secreted proteins |
| 12/24/2003 | WO2002072831A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/24/2003 | WO2002068676A3 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 12/24/2003 | WO2002066601A3 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam2 |
| 12/24/2003 | WO2002062947A8 Hematopoietic growth factor inducible neurokinin-1 gene |
| 12/24/2003 | WO2002061042A8 Genetic control of organ abscission |
| 12/24/2003 | WO2002059314A3 A human melanoma associated antigen and uses therefor |
| 12/24/2003 | WO2002057435A3 Bifunctional fusion proteins with glucocerebrosidase activity |
| 12/24/2003 | WO2002057311A3 Sphingosine 1-phosphate receptor gene, sppr |
| 12/24/2003 | WO2002057303A3 Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides |
| 12/24/2003 | WO2002048361A3 Novel secreted proteins and their uses |
| 12/24/2003 | WO2002046228A3 Receptor for b. anthracis toxin |
| 12/24/2003 | WO2002038730A3 Novel human potassium channel beta subunit |
| 12/24/2003 | WO2002026805A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/24/2003 | WO2002018580A3 54372, a novel human anion transporter and uses therefor |
| 12/24/2003 | DE20121979U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121977U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121974U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121973U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121972U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121971U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121970U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121969U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | DE20121965U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
| 12/24/2003 | CN1462755A Method for distilling active protein liquid of scorpion |
| 12/24/2003 | CN1462636A Vaccine of recombined albumen for preventing and treating infection of human C type hepatitis virus and its usage |
| 12/24/2003 | CN1132014C Icam－4抗体的应用 Icam-4 antibody applications |
| 12/24/2003 | CN1132011C Method for determining ready compound able to regulate cell proliferative diseases |
| 12/24/2003 | CN1131872C Modified factor VII |
| 12/24/2003 | CN1131712C Colostrinin and use thereof |
| 12/24/2003 | CN1131663C Hypersensitive response induced resistance in plants |
| 12/24/2003 | CA2490021A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 12/24/2003 | CA2489724A1 Immunogenic conjugates |
| 12/24/2003 | CA2489645A1 Pokeweed antiviral protein polypeptides with antiviral activity |
| 12/24/2003 | CA2489594A1 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 12/24/2003 | CA2489474A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 12/24/2003 | CA2489467A1 Humanized monoclonal antibody hpam4 |
| 12/24/2003 | CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | CA2489291A1 Vegetable protein preparations and use thereof |
| 12/24/2003 | CA2488876A1 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets |
| 12/24/2003 | CA2488782A1 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 12/24/2003 | CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | CA2488423A1 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation |
| 12/24/2003 | CA2487342A1 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| 12/24/2003 | CA2486649A1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 12/24/2003 | CA2479938A1 In vivo imaging of apoptosis |
| 12/24/2003 | CA2477878A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/23/2003 | US6667427 Genetic manipulation of plants with genes and promoters that enhance disease resistance. |
| 12/23/2003 | US6667426 Grapevine fanleaf virus resistance in grapevine expressing grapevine fanleaf virus coat protein |
| 12/23/2003 | US6667391 Can be used to produce monoclonal antibodies, as molecular weight markers, and as a food supplement. |
| 12/23/2003 | US6667390 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors, inflammation and shock |
| 12/23/2003 | US6667389 Technetium-99m labeled peptides for imaging |
| 12/23/2003 | US6667388 Peptide inhibitor of MMP activity and angiogenesis |
| 12/23/2003 | US6667387 Immunodominant epitope identified in the gp41 region of the HIV- 1 strain Ant70; in vitro determination of HIV-1-specific antibodies. |
| 12/23/2003 | US6667295 DNA vaccine against feline immunodeficiency virus |
| 12/23/2003 | US6667292 Metabolite is an s-nitroso-low molecular weight thiol compound, s-nitrosoglutathione; blood substitutes and organ perfusion solutions |
| 12/23/2003 | US6667291 Endometrial Steroid Binding Protein II activity; endometrial and breast cancers |
| 12/23/2003 | US6667173 Antiscarring agents; wound healing agents |
| 12/23/2003 | US6667169 Polypeptides having acid phosphatase activity and nucleic acids encoding same |
| 12/23/2003 | US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells. |
| 12/23/2003 | US6667157 Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus VPR protein |
| 12/23/2003 | US6667154 Contacting with an oligo- or polynucleotide that hybridizes to a specific sequence and comparing the amount of polynucleotide that hybridizes to the oligonucleotide to a predetermined cut-off value |
| 12/23/2003 | US6667152 Method for selective inactivation of viral replication |
| 12/23/2003 | US6667151 Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease |
| 12/23/2003 | US6667040 Bovine footrot treatment and prevention |
| 12/23/2003 | US6667039 Delivering therapeutic agent to CD30+ malignant cells by contacting with conjugate comprising one or more agents attached to soluble CD30 ligand polypeptide having specified amino acid sequence |
| 12/23/2003 | US6667038 Isolated peptide comprising specified amino acid sequence |
| 12/23/2003 | US6667037 Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof |
| 12/23/2003 | US6667036 Administering antibody to a protein component or to a carbohydrate-protein component of P-selectin glycoprotein ligand for therapy of rheumatoid arthritis |
| 12/23/2003 | US6667035 Isolated polypeptide which specifically binds and neutralizes Clostridium difficile enterotoxin (toxin A) |
| 12/23/2003 | US6667034 Human gene therapy; culture product; adjustment of metabolism; regeneration bone marrow |
| 12/23/2003 | US6667033 Administering daily effective dose of interferon-beta in two portions for four weeks |
| 12/23/2003 | US6667032 For diagnosis of disorders |
| 12/23/2003 | CA2149207C Compounds that inhibit t cell proliferation and methods using the same |
| 12/23/2003 | CA2087342C Serine protease variants having peptide ligase activity |
| 12/18/2003 | WO2003104932A2 Evolutionary algorithm for ion channels |
| 12/18/2003 | WO2003104818A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 12/18/2003 | WO2003104811A2 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases |
| 12/18/2003 | WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 12/18/2003 | WO2003104792A2 Method and system for multi-stage isoelectric focussing |
| 12/18/2003 | WO2003104493A1 Improvements in and relating to a method of dna testing for mycobacterium paratuberculosis strains |
| 12/18/2003 | WO2003104489A2 Mchr1 variant associated with human obesity |
| 12/18/2003 | WO2003104484A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators |
| 12/18/2003 | WO2003104480A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 12/18/2003 | WO2003104468A1 A semliki forest virus based expression vector for the central nervous system |
| 12/18/2003 | WO2003104465A1 Soybean promoter expressed preferentially in pods |
| 12/18/2003 | WO2003104464A1 Female gametophyte specific promoter (zmea1) |
| 12/18/2003 | WO2003104463A1 Transgenic expression constructs and method for increasing the vitamin e content in plant organisms |
| 12/18/2003 | WO2003104462A2 Regulation of gene expression using chromatin remodelling factors |
| 12/18/2003 | WO2003104461A1 Pigment protein |
| 12/18/2003 | WO2003104460A1 Pigment protein |
| 12/18/2003 | WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease |
| 12/18/2003 | WO2003104453A1 Method of constructing antibody |